| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Zymeworks Inc. (ZYME) has 14 insiders with recent SEC Form 4 filings, including 8 buys and 10 sells. ZYME is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 257.3K | $6.32M | - | |
| CFO | 178.0K | $4.37M | - | |
| COO | 66.0K | $1.62M | - | |
| Other | 58.1K | $1.43M | - | |
| VP | 36.0K | $885.0K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jan 6, 2025 | Galbraith Kenneth | Chair &CEO | Sale+OE | 57,291 | $14.92 | $855,016.61 | -30.9% | -27.9% | +67.2% | |
| Jan 6, 2025 | Smith Jeffrey T L | EVP &Chief Medical Officer | Sale+OE | 11,110 | $14.92 | $165,806.75 | -55.5% | -27.9% | +67.2% | |
| Jan 2, 2025 | Ecor1 Capital, LLC76 | Director, 10% Owner | Buy | 363,369 | $14.64 | $5,321,175.87 | +0.8% | -19.4% | +80.1% | |
| Dec 27, 2024 | Ecor1 Capital, LLC76 | Director, 10% Owner | Buy | 130,309 | $14.44 | $1,882,114.86 | +0.3% | -13.7% | +85.3% | |
| Jan 8, 2024 | Galbraith Kenneth | Chair &CEO | Sale+OE | 23,904 | $10.79 | $257,844.95 | -31.0% | -16.6% | +24.0% | |
| Jan 8, 2024 | Astle Christopher | SVP &Chief Financial Officer | Sale+OE | 5,994 | $10.79 | $64,655.51 | -29.3% | -16.6% | +24.0% | |
| Jan 8, 2024 | Moore Paul Andrew | Chief Scientific Officer | Sale+OE | 9,799 | $10.79 | $105,698.70 | -36.5% | -16.6% | +24.0% | |
| Dec 11, 2023 | Astle Christopher | SVP &Chief Financial Officer | Sale+OE | 886 | $9.13 | $8,089.27 | -30.7% | +19.8% | +41.6% | |
| Jun 16, 2023 | Ecor1 Capital, LLC76 | 10% Owner | Buy | 3,350,000 | $8.12 | $27,202,000.00 | +33.2% | -16.5% | +11.3% | |
| Mar 28, 2023 | Ecor1 Capital, LLC76 | - | Buy | 200,000 | $8.00 | $1,600,000.00 | +2.0% | -2.1% | +27.6% |